Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

CompletedOBSERVATIONAL
Enrollment

583

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Breast Cancer
Interventions
OTHER

Observational study no intervention

Observational study no intervention

Trial Locations (62)

4031

University Hospital Basel, Basel

10016

NYU Langone Health, New York

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical Center, New York

10461

Montefiore Medical Center, New York

14642

University of Rochester, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

18840

Guthrie Clinic, Sayre

19104

University of Pennsylvania, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

27710

Duke University, Durham

33136

Miami University, Miami

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic, Rochester

77030

The University of Texas, MD Anderson Cancer Center, Houston

85008

Valleywise Health Medical Center, Phoenix

90033

University of Southern California, Los Angeles

90048

Cedars-Sinai Medical Center, Samuel Oschin Cancer Institute, Los Angeles

98029

Swedish Cancer Institute, Seattle

98133

University of Washington, Seattle

02215

Dana Farber Cancer Institute, Boston

Unknown

Medical University of Vienna, Vienna

University Hospital Ghent, Ghent

Sirio-Libanes Hospital, Department of Oncology, Brasília

Nossa Senhora das Gracias Hospital, Curitiba

Instituto de Mastologia e Oncologia, Goiânia

Santa Paula Hospital, São Paulo

Sirio-Libanes Hospital, Department of Oncology, São Paulo

Mc Gill University, Montreal

Universitätsklinikum Augsburg, Augsburg

University Hospital Düsseldorf, Düsseldorf

KEM Evang. Kliniken Essen-Mitte, Essen

University Hospital Heidelberg, Heidelberg

University Hospital Schleswig-Holstein Campus Lübeck, Lübeck

German Breast Group, Neu-Isenburg

Athens Medical Center, Athens

Heraklion University Hospital, Heraklion

Sheba Medical Center, Tel Litwinsky

Instituto Nazionale Tumori (IRCCS), Naples

University of Naples Federico, Naples

Veneto Institute of Oncology IRCCS, Padua

Istituti Clinici Scientifici Maugeri IRCCS,, Pavia

IRCCS Humanitas Research Hospital, Rozzano

Antoni van Leeuwenhoek, Amsterdam

University Hospital of Zielona Góra, Zielona Góra

Institute of Oncology Ljubljana, Ljubljana

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Samsung Medical Center, Seoul

Hospital del Mar, Barcelona

Sahlgrenska University Hospital Gothenburg, Gothenburg

Kantonsspital Baden, Baden

Breastcenter Zürich, Zurich

University Hospital Zürich, Zurich

Gülhane Research and Training Hospital, Ankara

Acıbadem Research Instıtute of Senology, Istanbul

Istanbul University Institute of Oncology, Istanbul

Istanbul University, Faculty of Medicine, Istanbul

Marmara University, School of Medicine, Istanbul

Zonguldak Bulent Ecevit University, Zonguldak

Cambridge University Hospital, Cambridge

The Royal Marsden Hospital, London

All Listed Sponsors
collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT06464341 - Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study | Biotech Hunter | Biotech Hunter